FDA & Government News
Trump Takes Dual Action on Autism Crisis
-
By
September 22, 2025
-
2 min
-
1
FDA warns about autism risks linked to prenatal Tylenol use.
-
2
Pregnant women should limit Tylenol unless medically necessary.
-
3
FDA working on approving leucovorin for cerebral folate deficiency.
-
4
Increase in autism rates raises concerns; a 4-fold increase noted.
-
5
Key figures include Trump, Makary, Bhattacharya, Oz, and Kennedy Jr.
-
President Trump has announced that the FDA will warn physicians about potential autism risks linked to prenatal acetaminophen (Tylenol) use, urging pregnant women to limit its use unless medically necessary. This announcement comes as the FDA takes steps towards approving leucovorin calcium tablets as treatment for cerebral folate deficiency (CFD), a condition associated with developmental delays and autism-like features. The initiative is part of a broader response to a significant rise in autism rates over the past two decades, advocating for preventive and treatment measures.
-
1
FDA warns about autism risks linked to prenatal Tylenol use.
-
2
Pregnant women should limit Tylenol unless medically necessary.
-
3
FDA working on approving leucovorin for cerebral folate deficiency.
-
4
Increase in autism rates raises concerns; a 4-fold increase noted.
-
5
Key figures include Trump, Makary, Bhattacharya, Oz, and Kennedy Jr.
Listen Tab content
